explore
Previous article:
Continuity nursing helped my family in our darkest PICU moments
Next article: FDA rejects Alnylam's heart disease treatment over insufficient data
Next article: FDA rejects Alnylam's heart disease treatment over insufficient data
leisure time
leisure time
-
A Q&A with the global head of Boehringer Ingelheim's innovation unit
2025-09-27 23:15 -
The future of health care in the House
2025-09-27 23:03 -
Analysis of telehealth claims data suggest service duplication
2025-09-27 22:21 -
STAT Summit: GSK CEO on pharma giant's new direction
2025-09-27 22:06 -
2023 STAT Wunderkinds: get to know the winners
2025-09-27 22:05 -
FDA warns J&J's Abiomed: We will regulate your software
2025-09-27 21:24